These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 31677238)
1. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk. Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238 [TBL] [Abstract][Full Text] [Related]
2. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany. Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood. Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452 [TBL] [Abstract][Full Text] [Related]
4. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification. Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA. Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081 [TBL] [Abstract][Full Text] [Related]
6. Epigenome-wide association study of breast cancer using prospectively collected sister study samples. Xu Z; Bolick SC; DeRoo LA; Weinberg CR; Sandler DP; Taylor JA J Natl Cancer Inst; 2013 May; 105(10):694-700. PubMed ID: 23578854 [TBL] [Abstract][Full Text] [Related]
7. Gene-Environment Interactions and the Risk of Barrett's Esophagus in Three US Cohorts. Crous-Bou M; Jovani M; De Vivo I; Jacobson BC Am J Gastroenterol; 2019 Jun; 114(6):893-899. PubMed ID: 30950840 [TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161 [TBL] [Abstract][Full Text] [Related]
9. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation. Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172 [TBL] [Abstract][Full Text] [Related]
10. A Genetic Risk Score Improves the Prediction of Type 2 Diabetes Mellitus in Mexican Youths but Has Lower Predictive Utility Compared With Non-Genetic Factors. Miranda-Lora AL; Vilchis-Gil J; Juárez-Comboni DB; Cruz M; Klünder-Klünder M Front Endocrinol (Lausanne); 2021; 12():647864. PubMed ID: 33776940 [TBL] [Abstract][Full Text] [Related]
11. Assessing the clinical utility of a genetic risk score constructed using 49 susceptibility alleles for type 2 diabetes in a Japanese population. Imamura M; Shigemizu D; Tsunoda T; Iwata M; Maegawa H; Watada H; Hirose H; Tanaka Y; Tobe K; Kaku K; Kashiwagi A; Kawamori R; Maeda S J Clin Endocrinol Metab; 2013 Oct; 98(10):E1667-73. PubMed ID: 23956346 [TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic modifications of adiponectin gene: Potential association with breast cancer risk. Pasha HF; Mohamed RH; Toam MM; Yehia AM J Gene Med; 2019 Oct; 21(10):e3120. PubMed ID: 31415715 [TBL] [Abstract][Full Text] [Related]
13. The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies. Yang R; Stöcker S; Schott S; Heil J; Marme F; Cuk K; Chen B; Golatta M; Zhou Y; Sutter C; Wappenschmidt B; Schmutzler R; Bugert P; Qu B; Bartram CR; Sohn C; Schneeweiss A; Burwinkel B Carcinogenesis; 2017 Mar; 38(3):312-320. PubMed ID: 28426874 [TBL] [Abstract][Full Text] [Related]
14. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients. Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014 [TBL] [Abstract][Full Text] [Related]
15. [Application values of genome-wide association studies in screening for breast cancer]. Huang YB; Song FJ; Chen KX Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):713-718. PubMed ID: 31238625 [No Abstract] [Full Text] [Related]
16. Genetic Risk Score Is Associated with Vertical Cup-to-Disc Ratio and Improves Prediction of Primary Open-Angle Glaucoma in Latinos. Nannini DR; Kim H; Fan F; Gao X Ophthalmology; 2018 Jun; 125(6):815-821. PubMed ID: 29361357 [TBL] [Abstract][Full Text] [Related]
17. A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder. Hung CF; Breen G; Czamara D; Corre T; Wolf C; Kloiber S; Bergmann S; Craddock N; Gill M; Holsboer F; Jones L; Jones I; Korszun A; Kutalik Z; Lucae S; Maier W; Mors O; Owen MJ; Rice J; Rietschel M; Uher R; Vollenweider P; Waeber G; Craig IW; Farmer AE; Lewis CM; Müller-Myhsok B; Preisig M; McGuffin P; Rivera M BMC Med; 2015 Apr; 13():86. PubMed ID: 25903154 [TBL] [Abstract][Full Text] [Related]
18. Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction. Lee CP; Choi H; Soo KC; Tan MH; Chay WY; Chia KS; Liu J; Li J; Hartman M PLoS One; 2015; 10(9):e0136650. PubMed ID: 26401662 [TBL] [Abstract][Full Text] [Related]
19. Weighting approaches for a genetic risk score and an oxidative stress score for predicting the incidence of obesity. Park S; Yoo HJ; Jee SH; Lee JH; Kim M Diabetes Metab Res Rev; 2020 Feb; 36(2):e3230. PubMed ID: 31654550 [TBL] [Abstract][Full Text] [Related]
20. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer. Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]